These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 26883251)

  • 1. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.
    Chen YM; Liu Y; Wei HY; Lv KZ; Fu P
    Tumour Biol; 2016 Aug; 37(8):10861-70. PubMed ID: 26883251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205.
    Zhang HY; Liang F; Zhang JW; Wang F; Wang L; Kang XG
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):327-337. PubMed ID: 28063065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
    Lu PW; Li L; Wang F; Gu YT
    J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of long non-coding RNA ROR reverses resistance to Tamoxifen by inducing autophagy in breast cancer.
    Li Y; Jiang B; Zhu H; Qu X; Zhao L; Tan Y; Jiang Y; Liao M; Wu X
    Tumour Biol; 2017 Jun; 39(6):1010428317705790. PubMed ID: 28635401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linc-ROR promotes invasion and metastasis of gastric cancer by activating epithelial-mesenchymal transition.
    Liu M; Zhang M; Yin H
    Indian J Pathol Microbiol; 2022; 65(3):545-550. PubMed ID: 35900480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
    Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L
    Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and function of long intergenic non-protein coding RNA-regulator of reprogramming in high-grade ovarian serous cancer].
    Jiang HH; Lou YH; Wang XY; Han Y; Cui ZM
    Zhonghua Fu Chan Ke Za Zhi; 2016 Dec; 51(12):921-927. PubMed ID: 28057128
    [No Abstract]   [Full Text] [Related]  

  • 8. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
    Zhao T; Wu L; Li X; Dai H; Zhang Z
    Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R; Zhang J; Huang J; Hai T
    Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25.
    Yin C; Mou Q; Pan X; Zhang G; Li H; Sun Y
    Thorac Cancer; 2018 Apr; 9(4):472-479. PubMed ID: 29524309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer.
    Peng WX; Huang JG; Yang L; Gong AH; Mo YY
    Mol Cancer; 2017 Oct; 16(1):161. PubMed ID: 29041978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA TCONS_00068220 Promotes Breast Cancer Progression by Regulating Epithelial-Mesenchymal Transition Marker E-Cadherin.
    Liu X; Tian X
    Med Sci Monit; 2021 Mar; 27():e929832. PubMed ID: 33716295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis.
    Hou P; Zhao Y; Li Z; Yao R; Ma M; Gao Y; Zhao L; Zhang Y; Huang B; Lu J
    Cell Death Dis; 2014 Jun; 5(6):e1287. PubMed ID: 24922071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.
    Li Y; Su X; Pan H
    Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linc-ROR induces epithelial-to-mesenchymal transition in ovarian cancer by increasing Wnt/β-catenin signaling.
    Lou Y; Jiang H; Cui Z; Wang L; Wang X; Tian T
    Oncotarget; 2017 Sep; 8(41):69983-69994. PubMed ID: 29050257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
    Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells.
    Wang YY; Yan L; Yang S; Xu HN; Chen TT; Dong ZY; Chen SL; Wang WR; Yang QL; Chen CJ
    J Cell Physiol; 2019 Dec; 234(12):23202-23215. PubMed ID: 31215650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2.
    Zhou Q; Guo J; Huang W; Yu X; Xu C; Long X
    Mol Oncol; 2020 Sep; 14(9):2231-2250. PubMed ID: 32335998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.